NDC 53157-301

LEUKOSEP - SOLX B ADDITIVE SOLUTION

Solx B Additive Solution

LEUKOSEP - SOLX B ADDITIVE SOLUTION is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Manufacturing Inc. The primary component is Dextrose.

Product ID53157-301_795f1082-9ede-47cb-9a22-5092787ecbb3
NDC53157-301
Product TypeHuman Prescription Drug
Proprietary NameLEUKOSEP - SOLX B ADDITIVE SOLUTION
Generic NameSolx B Additive Solution
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2013-05-15
Marketing CategoryNDA / NDA
Application NumberNDA110059
Labeler NameHaemonetics Manufacturing Inc
Substance NameDEXTROSE
Active Ingredient Strength2 g/30mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 53157-301-01

30 mL in 1 BAG (53157-301-01)
Marketing Start Date2013-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53157-301-01 [53157030101]

LEUKOSEP - SOLX B ADDITIVE SOLUTION SOLUTION
Marketing CategoryNDA
Application NumberNDA110059
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-05-15
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE1.78 g/30mL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.